Hansen, F.J.* ; Mittelstädt, A.* ; Clausen, F.N.* ; Knoedler, S. ; Knoedler, L.* ; Klöckner, S.* ; Kuchenreuther, I.* ; Mazurie, J.* ; Arnold, L.S.* ; Anthuber, A.* ; Jacobsen, A.V.* ; Merkel, S.* ; Weisel, N.* ; Klösch, B.* ; Karabiber, A.* ; Tacyildiz, I.* ; Czubayko, F.* ; Reitberger, H.* ; Gendy, A.E.* ; Brunner, M.* ; Krautz, C.* ; Wolff, K.* ; Mihai, S.* ; Neufert, C.* ; Siebler, J.* ; Grützmann, R.* ; Weber, G.F.* ; David, P.*
CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients.
Sci. Rep. 14:21164 (2024)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, presenting a persisting global health burden. Neutrophils have a double-edged role in tumor progression exhibiting both pro-tumor and anti-tumor functions. CD71, also known as transferrin receptor 1, performs a critical role in cellular iron uptake and is highly expressed on proliferating cells, and especially on activated immune cells. CD71 is known to be elevated in various types of solid cancers and is associated with poor prognosis, however, the expression of CD71 on neutrophils in PDAC and its potential clinical impact is still unknown. Therefore, we analyzed CD71 on circulating neutrophils in PDAC and clinical control patients and found a significant increased expression in PDAC patients. High expression of CD71 on neutrophils in PDAC patients was associated with reduced outcome compared to low expression. CD71 on neutrophils correlated positively with the levels of proinflammatory cytokines IL-6, IFN-γ, and growth factor ligands CD40-L, and BAFF in plasma of PDAC patients. Finally, we have demonstrated that high expression of CD71 on neutrophils was also associated with an increased expression of CD39 and CD25 on circulating T-cells. Based on our findings, we hypothesize that CD71 on neutrophils is associated with tumor progression in PDAC. Further studies are required to investigate the distinct functionality of CD71 expressing neutrophils and their potential clinical application.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Cd71 ; Metastatic Spread ; Neutrophils ; Pancreatic Ductal Adenocarcinoma ; Prognostic Biomarker ; Transferrin Receptor 1; Transferrin Receptor Cd71; Ifn-gamma; T-cells; Cancer; Lymphocyte; Roles
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
2045-2322
e-ISSN
2045-2322
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 14,
Heft: 1,
Seiten: ,
Artikelnummer: 21164
Supplement: ,
Reihe
Verlag
Nature Publishing Group
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Regenerative Biology and Medicine (IRBM)
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Lung Research
PSP-Element(e)
G-509400-001
Förderungen
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2024-10-23